查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423580

到 2030 年 DNA 微阵列市场预测：按类型、技术、应用、最终用户和地区分類的全球分析

DNA Microarray Market Forecasts to 2030 - Global Analysis By Type (Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA) and Other Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球 DNA 微阵列市场规模将达到 37 亿美元，预计到 2030 年将达到 76 亿美元，预测期内复合年增长率为 10.7%。

DNA 微阵列是分子生物学中使用的强大工具，可在一次实验中同时分析数千个基因的表现量。 DNA 微阵列是包含 DNA 探针的微观斑点阵列，每个斑点代表一个特定的基因或基因片段。透过将萤光标记的 DNA 或 RNA 样本与这些点杂交，科学家可以检测和测量给定样本中数千个基因的表达水平，使科学家能够确定基因功能、调控，深入了解生物系统内的相互作用。这项技术在基因组学、遗传学和生物医学研究等领域至关重要。

加拿大癌症协会估计，加拿大已报告 233,900 例新癌症病例和 85,100 例死亡。

基因组学研究进展

DNA 微阵列市场的基因组学研究取得了重大进展，彻底改变了个人化医疗和疾病理解。微阵列技术的创新将推动基因表现、突变分析和基因组变异的研究。改进的生物资讯学工具简化了资料分析并能够全面洞察复杂的生物系统。这些进步将促进临床诊断、药物研发和生物标记识别的应用，为精准医学和标靶治疗铺平道路。

道德和隐私问题

DNA 微阵列引起了伦理问题，因为遗传资料可能被滥用，引发隐私、同意和歧视问题。收集的大量资料可能会被滥用，在未经知情同意的情况下使敏感的个人资讯面临风险。此外，人们还担心结果的准确性和解释，这可能会因不确定或误解的遗传资料而影响个人的生活。这些都是限制该产业发展的因素。

个人化医疗需求不断成长

由于对个人化医疗的兴趣日益浓厚，市场需求激增。这一趋势是由能够快速准确地分析个人遗传倾向和量身定制治疗计划的技术所推动的。随着医疗保健转向精准医疗，这些微阵列在深入了解基因突变、支持标靶治疗和改善患者治疗效果方面发挥着至关重要的作用。这种不断增长的需求证实了它在推动个人化医疗保健解决方案方面发挥的关键作用。

高成本

由于需要复杂的製造流程、专业设备和精确的品管措施，市场历来面临高成本。这些因素导致原物料成本、研发成本和生产成本急剧上升。此外，技术的复杂性以及对准确性和可靠性的要求进一步推高了成本，使得微阵列用于研究和诊断目的的投资昂贵。

COVID-19 的影响：

COVID-19大流行引起了DNA微阵列市场的波动。最初，供应链中断和实验室关闭导致市场放缓。然而，对诊断和研究目的的需求不断增加以及个人化医疗的进步促进了市场的成长。远距工作和资料分析技术的快速创新和适应也对市场产生了积极影响。总体而言，疫情造成了波动，但最终加速了技术进步和应用市场拓展。

药物基因体学领域预计在预测期内将是最大的

预计药物基因体学领域在预测期内将是最大的领域。此领域利用 DNA 微阵列来识别影响药物代谢、功效和副作用的遗传变异，从而实现个人化治疗方法。该行业的成长是由精准医疗的需求推动的，精准医疗的目标是实现量身定制的药物选择和管理，以改善患者的治疗效果，从而实现个性化的治疗性介入。它在护理行业中发挥着至关重要的作用。

预计诊断中心产业在预测期内复合年增长率最高

诊断中心领域预计在预测期内复合年增长率最高。这些中心使用微阵列同时检查大量基因，以识别与疾病相关的突变。微阵列平台的进步提高了准确性和通量，促进快速诊断和个人化治疗策略。这种市场区隔在解读遗传讯息、推动标靶治疗和精准医疗介入的创新方面发挥关键作用。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。该地区的市场成长是由基因组学、个人化医疗和生物技术投资不断增加所推动的。越来越多地采用先进医疗技术、策略联盟和支持性法规环境等因素正在促进市场扩张，满足研究、诊断和製药业的多样化应用。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。该地区市场对个人化医疗、基因研究和诊断的需求不断增长，推动了市场扩张。主要企业、策略联盟和政府对基因组学研究的支持正在促进市场的稳定成长。此外，医疗保健专业人员和研究人员对基因组技术的认识和采用的提高也推动了该地区的市场扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球 DNA 微阵列市场：依类型

  • 寡核苷酸 DNA 微阵列 (oDNA)
  • 互补 DNA 微阵列 (cDNA)
  • 其他类型

第六章全球 DNA 微阵列市场：依技术分类

  • 喷墨
  • 微流体学
  • 杂合反应
  • 其他技术

第七章 全球 DNA 微阵列市场：依应用分类

  • 药物基因组学
  • 基因表现分析
  • 癌症研究
  • 基因型鉴定
  • 蛋白质体学
  • 毒理基因组学
  • 遗传学
  • 药物研发
  • 法医调查
  • 神经科学
  • 其他用途

第八章 全球 DNA 微阵列市场：依最终使用者分类

  • 受託研究机构（CRO）
  • 生技公司
  • 医院和诊所
  • 学术研究所
  • 诊断中心
  • 其他最终用户

第九章全球 DNA 微阵列市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Applied Micro Arrays
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • PerkinElmer
  • Oxford Gene Technology（OGT）
  • Arrayit Corporation
  • Roche NimbleGen
  • Savyon Diagnostics
  • WaferGen Biosystems
  • Novacyt Group
  • Enzo Biochem, Inc.
Product Code: SMRC24814

According to Stratistics MRC, the Global DNA Microarray Market is accounted for $3.7 billion in 2023 and is expected to reach $7.6 billion by 2030 growing at a CAGR of 10.7% during the forecast period. A DNA microarray is a powerful tool used in molecular biology to simultaneously analyze the expression levels of thousands of genes in a single experiment. It consists of an arrayed series of microscopic spots containing DNA probes, each spot representing a specific gene or fragment of a gene. By hybridizing fluorescently labelled DNA or RNA samples onto these spots, scientists can detect and measure the expression levels of thousands of genes in a given sample, providing insights into gene function, regulation, and interactions within biological systems. This technology has been pivotal in fields like genomics, genetics, and biomedical research.

According to estimates by the Canadian Cancer Society, the country reported 233,900 new cancer cases with 85,100 deaths.

Market Dynamics:

Driver:

Advancements in genomics research

Genomics research within the DNA Microarray market has witnessed substantial advancements, revolutionizing personalized medicine and disease understanding. Innovations in microarray technology propel research in gene expression, mutation analysis, and genomic variations. Improved bioinformatics tools streamline data analysis, enabling comprehensive insights into complex biological systems. These advancements foster applications in clinical diagnostics, drug discovery, and biomarker identification, paving the way for precision medicine and targeted therapies.

Restraint:

Ethical and privacy concerns

DNA Microarrays pose ethical concerns due to potential misuse of genetic data, raising issues of privacy infringement, consent, and discrimination. The vast data collected can be exploited, compromising individuals' sensitive information without their informed consent. Additionally, concerns arise regarding the accuracy and interpretation of results, potentially impacting individuals' lives based on uncertain or misinterpreted genetic data. These are the factors restraining the growth of the segment.

Opportunity:

Rising demand for personalized medicine

The market is witnessing a surge in demand due to the growing interest in personalized medicine. This trend is fuelled by the technology's ability to analyze an individual's genetic makeup swiftly and accurately, enabling tailored treatment plans. As healthcare shifts toward precision medicine, these microarrays play a pivotal role by offering insights into genetic variations, aiding in targeted therapies, and enhancing patient outcomes. This rising demand underscores the pivotal role in advancing personalized healthcare solutions.

Threat:

High costs

The market has historically faced high costs due to intricate manufacturing processes, specialized equipment, and the need for precise quality control measures. These factors contribute to elevated expenses in raw materials, research, development, and production. Additionally, the complexity of the technology and the demand for accuracy and reliability further drives up costs, making microarrays a costly investment for research and diagnostic purposes.

Covid-19 Impact:

The COVID-19 pandemic triggered fluctuations in the DNA Microarray market. Initially, disruptions in supply chains and lab closures led to a slowdown. However, increased demand for diagnostics and research purposes, along with advancements in personalized medicine, boosted market growth. Rapid innovation and adaptation in technology for remote work and data analysis also influenced the market positively. Overall, the pandemic caused fluctuations but ultimately accelerated technological advancements and market expansion in applications.

The Pharmacogenomics segment is expected to be the largest during the forecast period

The pharmacogenomics segment is expected to be the largest during the forecast period. This segment utilizes DNA microarrays to identify genetic variations influencing drug metabolism, efficacy, and adverse reactions, guiding personalized treatment approaches. Its growth is driven by the demand for precision medicine, enabling tailored drug selection and dosing for better patient outcomes, making it a pivotal player in the healthcare industry's quest for personalized therapeutic interventions.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

The diagnostic centers segment is expected to have the highest CAGR during the forecast period. These centers employ microarrays to simultaneously examine numerous genes, identifying variations linked to illnesses. Advancements in microarray platforms enhance precision and throughput, fostering quicker diagnoses and personalized treatment strategies. This market segment thrives due to its pivotal role in decoding genetic information, driving innovation for targeted therapies and precise medical interventions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region's market growth is propelled by rising investments in genomics, personalized medicine, and biotechnology. Factors such as increased adoption of advanced healthcare technologies, strategic collaborations, and a supportive regulatory environment contribute to the market's expansion, catering to diverse applications across research, diagnostics, and pharmaceutical industries.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The region's market witnesses escalating demand for personalized medicine, genetic research, and diagnostics, fostering market expansion. Key players, strategic collaborations, and government support for genomics research contribute to the market's steady rise. Moreover, growing awareness and adoption of genomic technologies among healthcare professionals and researchers further fuel the market's evolution in the region.

Key players in the market

Some of the key players in DNA Microarray market include Applied Micro Arrays, Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, PerkinElmer, Oxford Gene Technology (OGT), Arrayit Corporation, Roche NimbleGen, Savyon Diagnostics, WaferGen Biosystems, Novacyt Group and Enzo Biochem, Inc.

Key Developments:

In August 2022, Thermo Fisher Scientific launched a new chromosomal microarray, the Applied Biosystem CytoScan HD Accel array, to improve cytogenetic research lab productivity, efficiency, and profitability with two-day turnaround time. This strategy helped the company to expand their product portfolio.

In May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Types Covered:

  • Oligonucleotide DNA Microarrays (oDNA)
  • Complementary DNA Microarrays (cDNA)
  • Other Types

Technologies Covered:

  • Inkjet
  • Microfluidics
  • Hybridization
  • Other Technologies

Applications Covered:

  • Gene Expression Analysis
  • Cancer Research
  • Genotyping
  • Genetics
  • Drug Discovery
  • Forensic Science
  • Neuroscience
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global DNA Microarray Market, By Type

  • 5.1 Introduction
  • 5.2 Oligonucleotide DNA Microarrays (oDNA)
  • 5.3 Complementary DNA Microarrays (cDNA)
  • 5.4 Other Types

6 Global DNA Microarray Market, By Technology

  • 6.1 Introduction
  • 6.2 Inkjet
  • 6.3 Microfluidics
  • 6.4 Hybridization
  • 6.5 Other Technologies

7 Global DNA Microarray Market, By Application

  • 7.1 Introduction
  • 7.2 Pharmacogenomics
  • 7.3 Gene Expression Analysis
  • 7.4 Cancer Research
  • 7.5 Genotyping
  • 7.6 Proteomics
  • 7.7 Toxicogenomics
  • 7.8 Genetics
  • 7.9 Drug Discovery
  • 7.10 Forensic Science
  • 7.11 Neuroscience
  • 7.12 Other Applications

8 Global DNA Microarray Market, By End User

  • 8.1 Introduction
  • 8.2 Contract Research Organizations (CROs)
  • 8.3 Biotechnology Companies
  • 8.4 Hospitals and Clinics
  • 8.5 Academic and Research Institutes
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global DNA Microarray Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Applied Micro Arrays
  • 11.2 Illumina, Inc.
  • 11.3 QIAGEN
  • 11.4 F. Hoffmann-La Roche Ltd.
  • 11.5 Thermo Fisher Scientific, Inc.
  • 11.6 PerkinElmer, Inc.
  • 11.7 Merck KGaA
  • 11.8 Agilent Technologies, Inc.
  • 11.9 Bio-Rad Laboratories
  • 11.10 PerkinElmer
  • 11.11 Oxford Gene Technology (OGT)
  • 11.12 Arrayit Corporation
  • 11.11 Roche NimbleGen
  • 11.14 Savyon Diagnostics
  • 11.15 WaferGen Biosystems
  • 11.16 Novacyt Group
  • 11.17 Enzo Biochem, Inc.

List of Tables

  • Table 1 Global DNA Microarray Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global DNA Microarray Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global DNA Microarray Market Outlook, By Oligonucleotide DNA Microarrays (oDNA) (2021-2030) ($MN)
  • Table 4 Global DNA Microarray Market Outlook, By Complementary DNA Microarrays (cDNA) (2021-2030) ($MN)
  • Table 5 Global DNA Microarray Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global DNA Microarray Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global DNA Microarray Market Outlook, By Inkjet (2021-2030) ($MN)
  • Table 8 Global DNA Microarray Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 9 Global DNA Microarray Market Outlook, By Hybridization (2021-2030) ($MN)
  • Table 10 Global DNA Microarray Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global DNA Microarray Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global DNA Microarray Market Outlook, By Gene Expression Analysis (2021-2030) ($MN)
  • Table 13 Global DNA Microarray Market Outlook, By Cancer Research (2021-2030) ($MN)
  • Table 14 Global DNA Microarray Market Outlook, By Genotyping (2021-2030) ($MN)
  • Table 15 Global DNA Microarray Market Outlook, By Genetics (2021-2030) ($MN)
  • Table 16 Global DNA Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 17 Global DNA Microarray Market Outlook, By Forensic Science (2021-2030) ($MN)
  • Table 18 Global DNA Microarray Market Outlook, By Neuroscience (2021-2030) ($MN)
  • Table 19 Global DNA Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 20 Global DNA Microarray Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global DNA Microarray Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 22 Global DNA Microarray Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 23 Global DNA Microarray Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 24 Global DNA Microarray Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global DNA Microarray Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 26 Global DNA Microarray Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.